[1]
Muraleedharan, T. and Balan, A. 2026. Integrating Immunotherapy and Targeted Therapy in Advanced Hepatocellular Carcinoma: Clinical Outcomes of Lenvatinib–Pembrolizumab Combination Therapy. International Journal of Medical Students. (Aug. 2026).